Adma Biologics (ADMA) is down -19.9%, or -$1.92 to $7.71.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA:
- Cantor downgrades Adma Biologics on lack of clarity post short report
- Adma Biologics says Culper report contains ‘inaccurate statements’
- Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald
- Adma Biologics falls -12.6%
- Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded